Search Results

Your Guide to Feel-Good Joints.

Subjects: DISEASE progression; SLEEP quality; REGULATION of body weight

• Source: Consumer Reports on Health. Aug2023, Vol. 35 Issue 8, p6-7. 2p. 2 Color Photographs.

Record details

Tai Chi for Parkinson's.

Subjects: DISEASE progression; TAI chi; PARKINSON'S disease

• Source: Consumer Reports on Health. Feb2024, Vol. 36 Issue 2, p3-3. 1/5p. 1 Color Photograph.

Record details

Plagues upon the Earth: Disease and the Course of Human History.

• Authors : Rhode, Paul W.¹ (AUTHOR)

Subjects: DISEASE progressionUNIVERSITY of Michigan

• Source: Journal of Economic Literature. Jun2024, Vol. 62 Issue 2, p809-811. 3p.

Record details

FDA Sets Review Date for Linvoseltamab for Advanced Multiple Myeloma.

Subjects: DISEASE progression; CYTOKINES; MONOCLONAL antibodiesUNITED States. Food & Drug Administration

• Source: Formulary Watch. 2/21/2024, p2-2. 1p.

Record details

FDA Sets Advisory Meeting for Abecma in Supplemental Multiple Myeloma Indication.

Subjects: *MEETINGS; *COMMITTEES; DISEASE progressionUNITED States. Food & Drug Administration

• Source: Formulary Watch. 2/5/2024, p1-1. 1p.

Record details

Coherus Launches Loqtorzi for Nasopharyngeal Carcinoma.

Subjects: *PHARMACEUTICAL industry; *MEDICARE; NASOPHARYNX cancer

• Source: Formulary Watch. 1/2/2024, p1-1. 1p.

Record details

FDA Approves First Treatment for Rare Noncancerous Tumors.

Subjects: *ENDOWMENTS; TUMOR treatment; DISEASE progressionUNITED States. Food & Drug Administration

• Source: Formulary Watch. 11/28/2023, p1-1. 1p.

Record details

Drug: Elacestrant.

• Authors : Khandan; Franceschetti, Alessandra

Subjects: DISEASE progression; SELECTIVE estrogen receptor modulators; TREATMENT effectiveness

• Source: Medical Marketing & Media. Nov/Dec2022, Vol. 57 Issue 9, p38-39. 2p.

Record details

New study show SARS-CoV-2 infects fat tissue.

Subjects: *SARS-CoV-2; *COVID-19; OBESITY risk factors

• Source: Healthcare Purchasing News. Nov2022, Vol. 46 Issue 11, p6-8. 2p.

Record details

FDA Approves Welireg for Advanced Kidney Cancer.

Subjects: DRUG approval; RENAL cell carcinoma; DISEASE progressionUNITED States. Food & Drug Administration

• Source: Formulary Watch. 12/15/2023, p1-2. 2p.

Record details